🟢 HCW Biologics is trading 6.92% up in pre-market; no definitive catalyst identified

HCW Biologics is trading 6.92% up at $2.78 after closing at $2.60 on August 25, 2026, with no definitive catalyst identified.

• No new company-specific announcement dated August 26 was identified.
• The latest listed release, dated August 14, was the second-quarter report covering clinical developments and financial results.
• The move may reflect continued interest following recent biotech-sector strength.